Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Andrew Musgrave. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Musgrave or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

ARCHER MATERIALS LTD (AXE) - Quantum Leaps and Biotech Breakthroughs

12:00
 
Share
 

Manage episode 488629051 series 3570035
Content provided by Andrew Musgrave. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Musgrave or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Quantum computing breakthroughs and revolutionary medical diagnostics might sound like distant future technologies, but Archer Materials is bringing them to life right now. Our fascinating conversation with Dr Simon Ruffell, recently promoted from CTO to CEO, reveals how this Australian semiconductor company is simultaneously advancing two groundbreaking technologies with global implications.
Archer's quantum computing program has reached several crucial technical milestones, including extended spin lifetimes in carbon-based quantum films and successful coupling to superconducting resonators. These achievements might sound complex, but they represent fundamental building blocks toward creating functional qubits - the essential components of quantum computers.
Meanwhile, Archer's biochip program is moving rapidly toward practical applications. Their breakthrough technology can detect potassium levels in blood samples - crucial for monitoring chronic kidney disease. Recent achievements include integrating sophisticated graphene sensors with silicon circuitry and dramatically improving measurement consistency from 15% variability down to just 1.5%. By the end of 2024, they aim to demonstrate a prototype that can analyse blood samples in minutes, transitioning from laboratory demonstrations to tangible, functional hardware.
With $15 million in cash reserves, strong technical progress on both fronts, and a leadership team bringing experience from technology giants like Microsoft and Applied Materials, Archer Materials represents a fascinating intersection of cutting-edge science and commercial potential. Subscribe now to hear more stories of Australian innovation making global impacts!

  continue reading

Chapters

1. ARCHER MATERIALS LTD (AXE) - Quantum Leaps and Biotech Breakthroughs (00:00:00)

2. Introduction to Archer Materials (00:00:05)

3. Qubit Development Progress (00:01:24)

4. Biochip Integration and Testing (00:04:14)

5. Financial Position and Capital Strategy (00:07:05)

6. Leadership Transition and Future Milestones (00:09:52)

7. Episode Closing (00:11:00)

143 episodes

Artwork
iconShare
 
Manage episode 488629051 series 3570035
Content provided by Andrew Musgrave. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Musgrave or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Quantum computing breakthroughs and revolutionary medical diagnostics might sound like distant future technologies, but Archer Materials is bringing them to life right now. Our fascinating conversation with Dr Simon Ruffell, recently promoted from CTO to CEO, reveals how this Australian semiconductor company is simultaneously advancing two groundbreaking technologies with global implications.
Archer's quantum computing program has reached several crucial technical milestones, including extended spin lifetimes in carbon-based quantum films and successful coupling to superconducting resonators. These achievements might sound complex, but they represent fundamental building blocks toward creating functional qubits - the essential components of quantum computers.
Meanwhile, Archer's biochip program is moving rapidly toward practical applications. Their breakthrough technology can detect potassium levels in blood samples - crucial for monitoring chronic kidney disease. Recent achievements include integrating sophisticated graphene sensors with silicon circuitry and dramatically improving measurement consistency from 15% variability down to just 1.5%. By the end of 2024, they aim to demonstrate a prototype that can analyse blood samples in minutes, transitioning from laboratory demonstrations to tangible, functional hardware.
With $15 million in cash reserves, strong technical progress on both fronts, and a leadership team bringing experience from technology giants like Microsoft and Applied Materials, Archer Materials represents a fascinating intersection of cutting-edge science and commercial potential. Subscribe now to hear more stories of Australian innovation making global impacts!

  continue reading

Chapters

1. ARCHER MATERIALS LTD (AXE) - Quantum Leaps and Biotech Breakthroughs (00:00:00)

2. Introduction to Archer Materials (00:00:05)

3. Qubit Development Progress (00:01:24)

4. Biochip Integration and Testing (00:04:14)

5. Financial Position and Capital Strategy (00:07:05)

6. Leadership Transition and Future Milestones (00:09:52)

7. Episode Closing (00:11:00)

143 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play